The Department of Psychiatry offers continuing medical education (CME) through NYU Grossman School of Medicine for psychiatrists and other interested health professionals on the latest developments in mental health. Our CME offerings include the following:

• weekly Psychiatry Grand Rounds is a lecture series featuring NYU Langone thought leaders and others on topics including evidence-based clinical updates in psychiatric care, cutting-edge research in psychiatric disorders and treatment, and mental health delivery services
• monthly Behavioral Health/Psychology Grand Rounds is a lecture series on best practices in evidence-based psychotherapy and intervention, diagnostic assessment, and neuropsychology, as well as current research updates in psychology and psychiatry
• full-day continuing medical education courses

NYU Grossman School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

We also offer continuing education (CE) credits for psychologists. NYU Langone Health and NYU Grossman School of Medicine are recognized by the New York State Education Department’s State Board for Psychology as an approved provider of CE for licensed psychologists, #PSY-0085.

Full-Day Continuing Medical Education Courses

Annual Psychopharmacology Review

Saturday, March 4, 2023

The Annual Psychopharmacology Review provides expert perspectives on major public health concerns, including bipolar disorder, major depression, addiction, treatment and prevention of post-traumatic stress disorder (PTSD), psychiatric issues during peripregnancy, and treatment of patients with attention deficit hyperactivity disorder (ADHD). The pharmacologic treatment of people with psychiatric disorders continues to evolve as new drugs emerge and we improve our understanding of the risks and benefits of existing therapies. Clinicians are challenged to use medications effectively while balancing potential risk information from U.S. Food and Drug Administration (FDA) safety warnings and studies reporting previously unrecognized side effects.